Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation
Authors
Keywords
-
Journal
Cell Communication and Signaling
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-12
DOI
10.1186/s12964-021-00704-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Re-epithelialization and immune cell behaviour in an ex vivo human skin model
- (2020) Ana Rakita et al. Scientific Reports
- Role of cysteines in accelerating Tau filament formation
- (2020) Hariharakrishnan Chidambaram et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Protein-Capped Metal Nanoparticles Inhibit Tau Aggregation in Alzheimer’s Disease
- (2019) Shweta Kishor Sonawane et al. ACS Omega
- Molecular Cobalt(II) Complexes for Tau Polymerization in Alzheimer’s Disease
- (2019) Nalini Vijay Gorantla et al. ACS Omega
- Baicalein suppresses Repeat Tau fibrillization by sequestering oligomers
- (2019) Shweta Kishor Sonawane et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer's disease
- (2019) Tushar Dubey et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Melatonin interacts with repeat domain of Tau to mediate disaggregation of paired helical filaments
- (2019) Abhishek Ankur Balmik et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Spreading of Tau Pathology in Sporadic Alzheimer’s Disease Along Cortico-cortical Top-Down Connections
- (2018) Heiko Braak et al. CEREBRAL CORTEX
- Natural Polyphenols in the Treatment of Alzheimer’s Disease
- (2018) Syed-Badrul Syarifah-Noratiqah et al. CURRENT DRUG TARGETS
- Prion-Like Propagation of Post-Translationally Modified Tau in Alzheimer’s Disease: A Hypothesis
- (2018) Shweta Kishor Sonawane et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Natural polyphenols effects on protein aggregates in Alzheimer's and Parkinson's prion-like diseases
- (2018) AgnèsRioux Bilan et al. Neural Regeneration Research
- Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
- (2018) Fuyuki Kametani et al. Frontiers in Neuroscience
- Interaction of Cinnamaldehyde and Epicatechin with Tau: Implications of Beneficial Effects in Modulating Alzheimer's Disease Pathogenesis
- (2018) Roshni C. George et al. JOURNAL OF ALZHEIMERS DISEASE
- Comprehensive review of antimicrobial activities of plant flavonoids
- (2018) Ireneusz Górniak et al. PHYTOCHEMISTRY REVIEWS
- Biocompatible nanoemulsions based on hemp oil and less surfactants for oral delivery of baicalein with enhanced bioavailability
- (2017) Juntao Yin et al. International Journal of Nanomedicine
- Curcumin Inhibits Tau Aggregation and Disintegrates Preformed Tau Filaments in vitro
- (2017) Jitendra Subhash Rane et al. JOURNAL OF ALZHEIMERS DISEASE
- Alzheimer’s Disease: Past, Present, and Future
- (2017) Mark W. Bondi et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Neuroprotective Effects of Baicalein on Acrolein-induced Neurotoxicity in the Nigrostriatal Dopaminergic System of Rat Brain
- (2017) Wei-Zhong Zhao et al. MOLECULAR NEUROBIOLOGY
- A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
- (2017) Jun Wang et al. Nature Reviews Neurology
- The Effects of Baicalin and Baicalein on Cerebral Ischemia: A Review
- (2017) Wei Liang et al. Aging and Disease
- Resveratrol Attenuates Formaldehyde Induced Hyperphosphorylation of Tau Protein and Cytotoxicity in N2a Cells
- (2017) Xiaping He et al. Frontiers in Neuroscience
- Cinnamon Extract Inhibits Tau Aggregation Associated with Alzheimer's Disease In Vitro
- (2017) Dylan W. Peterson et al. JOURNAL OF ALZHEIMERS DISEASE
- 2016 Alzheimer's disease facts and figures
- (2016) Alzheimers & Dementia
- The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer’s disease
- (2016) Xun-Hu Gu et al. BEHAVIOURAL BRAIN RESEARCH
- Neuroprotective Role of Natural Polyphenols
- (2016) Carmela Spagnuolo et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Baicalein attenuates α-synuclein aggregation, inflammasome activation and autophagy in the MPP+-treated nigrostriatal dopaminergic system in vivo
- (2016) Kai-Chih Hung et al. JOURNAL OF ETHNOPHARMACOLOGY
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- Tau Structures
- (2016) Jesus Avila et al. Frontiers in Aging Neuroscience
- Tau in physiology and pathology
- (2015) Yipeng Wang et al. NATURE REVIEWS NEUROSCIENCE
- Baicalein prevents human prion protein-induced neuronal cell death by regulating JNK activation
- (2014) JI-HONG MOON et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction
- (2014) Anna Mietelska-Porowska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Stages and Conformations of the Tau Repeat Domain during Aggregation and Its Effect on Neuronal Toxicity
- (2014) Satish Kumar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Baicalin, a metabolite of baicalein with antiviral activity against dengue virus
- (2014) Ehsan Moghaddam et al. Scientific Reports
- Mechanistic Basis of Phenothiazine-Driven Inhibition of Tau Aggregation
- (2013) Elias Akoury et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Interaction between baicalein and amyloid-β fibrils studied by fluorescence spectroscopy
- (2013) Sheng-mei Song et al. CHEMICAL RESEARCH IN CHINESE UNIVERSITIES
- Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation
- (2013) Alex Crowe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Insights into antiamyloidogenic properties of the green tea extract (-)-epigallocatechin-3-gallate toward metal-associated amyloid- species
- (2013) S.-J. Hyung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Natural polyphenols against neurodegenerative disorders: Potentials and pitfalls
- (2012) Azadeh Ebrahimi et al. AGEING RESEARCH REVIEWS
- The Synaptic Accumulation of Hyperphosphorylated Tau Oligomers in Alzheimer Disease Is Associated With Dysfunction of the Ubiquitin-Proteasome System
- (2012) Hwan-Ching Tai et al. AMERICAN JOURNAL OF PATHOLOGY
- Structural Properties of EGCG-Induced, Nontoxic Alzheimer's Disease Aβ Oligomers
- (2012) Juan Miguel Lopez del Amo et al. JOURNAL OF MOLECULAR BIOLOGY
- Synapses and Alzheimer's Disease
- (2012) M. Sheng et al. Cold Spring Harbor Perspectives in Biology
- Baicalein Inhibits Formation of α-Synuclein Oligomers within Living Cells and Prevents Aβ Peptide Fibrillation and Oligomerisation
- (2011) Jia-Hong Lu et al. CHEMBIOCHEM
- Post-translational modifications of tau protein: Implications for Alzheimer's disease
- (2011) Ludovic Martin et al. NEUROCHEMISTRY INTERNATIONAL
- Baicalein inhibits oxidative stress-induced cellular damage via antioxidant effects
- (2011) Kyoung Ah Kang et al. TOXICOLOGY AND INDUSTRIAL HEALTH
- Oxidative stress and Alzheimer’s disease: dietary polyphenols as potential therapeutic agents
- (2010) Altaf S Darvesh et al. Expert Review of Neurotherapeutics
- Binding Modes of Flavones to Human Serum Albumin: Insights from Experimental and Computational Studies
- (2010) Hui Liu et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau
- (2009) Wenkai Li et al. JOURNAL OF NEUROCHEMISTRY
- Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
- (2009) Diane P. Hanger et al. TRENDS IN MOLECULAR MEDICINE
- Structural Characteristics of α-Synuclein Oligomers Stabilized by the Flavonoid Baicalein
- (2008) Dong-Pyo Hong et al. JOURNAL OF MOLECULAR BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started